Clinical Trials at CMAX
Established in 1993, CMAX is one of Australia’s largest, longest running and most experienced, dedicated clinical trials unit.
Our team specialises in a range of early-phase clinical trials, including first-time in human-studies – of which we’ve conducted more than 100 to date.
With an impressive global regulatory history and a database of more than 13,000 active volunteers, our brand new 50-bed Phase I (through to Phase II-IV) unit includes a 24-bed ambulatory cardiac telemetry monitoring system and is centrally located to Adelaide’s Bio-med City.
How clinical trials test new treatments in order to find improved ways to prevent or treat illnesses.
Learn more about some of the recent trials
Helping yourself and others and being part of improving health care for everyone.
AUSTRALIAN R&D TAX INCENTIVES
All of our studies are fully ICH GCP compliant and comply with the registration requirements of the US FDA, EMEA, Japanese MHW and Canadian HPB; we have been US FDA-audited.
We can assist our overseas clients register for the Australian R&D Tax Incentive scheme. This allows eligible companies to claim up to 43.5 Cents in the Dollar Cash Rebate on qualifying R&D spend or 38.5% Tax Shield via R&D Tax Incentive – for more information contact our experienced team today.